APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flunixin Meglumine Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Flunixin Meglumine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchFlunixin Meglumine Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Flunixin Meglumine Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Flunixin Meglumine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flunixin Meglumine Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Flunixin Meglumine Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Flunixin Meglumine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Flunixin Meglumine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Flunixin Meglumine Injection include Wuhan Huisheng Biological Technology Co., Ltd., Shandong Zhongmu Veterinary Medicine Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Qilu Animal Health Products Co., Ltd., Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd., Hebei New Century Pharmaceutical Co., Ltd., Baimukang Animal Pharmaceutical Co., Ltd., Zoteis and Virbac Animal Health India Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flunixin Meglumine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flunixin Meglumine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flunixin Meglumine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flunixin Meglumine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Flunixin Meglumine Injection Segment by Company

Wuhan Huisheng Biological Technology Co., Ltd.

Shandong Zhongmu Veterinary Medicine Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Qilu Animal Health Products Co., Ltd.

Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.

Hebei New Century Pharmaceutical Co., Ltd.

Baimukang Animal Pharmaceutical Co., Ltd.

Zoteis

Virbac Animal Health India Private Limited

Norbrook

MSD Animal Health

Merck Animal Health

Bengal Remedies Limited

Flunixin Meglumine Injection Segment by Type

10ml/Dose

20ml/ Dose

Flunixin Meglumine Injection Segment by Application

Animal muscle pain

Animal febrile disease

Others

Flunixin Meglumine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flunixin Meglumine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flunixin Meglumine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flunixin Meglumine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flunixin Meglumine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Flunixin Meglumine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Flunixin Meglumine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Flunixin Meglumine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Flunixin Meglumine Injection Industry Trends Table 2. Flunixin Meglumine Injection Industry Drivers Table 3. Flunixin Meglumine Injection Industry Opportunities and Challenges Table 4. Flunixin Meglumine Injection Industry Restraints Table 5. Global Flunixin Meglumine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Flunixin Meglumine Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Flunixin Meglumine Injection Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global Flunixin Meglumine Injection Sales Market Share by Manufacturers Table 9. Global Flunixin Meglumine Injection Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Flunixin Meglumine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Flunixin Meglumine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Flunixin Meglumine Injection Manufacturers, Product Type & Application Table 13. Global Flunixin Meglumine Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Flunixin Meglumine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10ml/Dose Table 17. Major Manufacturers of 20ml/ Dose Table 18. Global Flunixin Meglumine Injection Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 19. Global Flunixin Meglumine Injection Sales by Type (2021-2026) & (K Doses) Table 20. Global Flunixin Meglumine Injection Sales by Type (2027-2032) & (K Doses) Table 21. Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2026) Table 22. Global Flunixin Meglumine Injection Sales Market Share by Type (2027-2032) Table 23. Global Flunixin Meglumine Injection Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 24. Global Flunixin Meglumine Injection Revenue by Type (2021-2026) & (K Doses) Table 25. Global Flunixin Meglumine Injection Revenue by Type (2027-2032) & (K Doses) Table 26. Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2026) Table 27. Global Flunixin Meglumine Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Animal muscle pain Table 29. Major Manufacturers of Animal febrile disease Table 30. Major Manufacturers of Others Table 31. Global Flunixin Meglumine Injection Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 32. Global Flunixin Meglumine Injection Sales by Application (2021-2026) & (K Doses) Table 33. Global Flunixin Meglumine Injection Sales by Application (2027-2032) & (K Doses) Table 34. Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2026) Table 35. Global Flunixin Meglumine Injection Sales Market Share by Application (2027-2032) Table 36. Global Flunixin Meglumine Injection Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 37. Global Flunixin Meglumine Injection Revenue by Application (2021-2026) & (K Doses) Table 38. Global Flunixin Meglumine Injection Revenue by Application (2027-2032) & (K Doses) Table 39. Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2026) Table 40. Global Flunixin Meglumine Injection Revenue Market Share by Application (2027-2032) Table 41. Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 42. Global Flunixin Meglumine Injection Sales by Region (2021-2026) & (K Doses) Table 43. Global Flunixin Meglumine Injection Sales Market Share by Region (2021-2026) Table 44. Global Flunixin Meglumine Injection Sales Forecasted by Region (2027-2032) & (K Doses) Table 45. Global Flunixin Meglumine Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 47. North America Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 48. North America Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 49. Europe Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 50. Europe Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 51. Europe Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 52. Asia Pacific Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 53. Asia Pacific Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 54. Asia Pacific Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 55. South America, Middle East and Africa Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 56. South America, Middle East and Africa Flunixin Meglumine Injection Sales by Country (2021-2026) & (K Doses) Table 57. South America, Middle East and Africa Flunixin Meglumine Injection Sales by Country (2027-2032) & (K Doses) Table 58. Global Flunixin Meglumine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Flunixin Meglumine Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Flunixin Meglumine Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Flunixin Meglumine Injection Revenue Market Share by Region (2021-2026) Table 62. Global Flunixin Meglumine Injection Revenue Market Share by Region (2027-2032) Table 63. Wuhan Huisheng Biological Technology Co., Ltd. Company Information Table 64. Wuhan Huisheng Biological Technology Co., Ltd. Business Overview Table 65. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 67. Wuhan Huisheng Biological Technology Co., Ltd. Recent Development Table 68. Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information Table 69. Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview Table 70. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 72. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Development Table 73. Shandong Lukang Pharmaceutical Co., Ltd. Company Information Table 74. Shandong Lukang Pharmaceutical Co., Ltd. Business Overview Table 75. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 77. Shandong Lukang Pharmaceutical Co., Ltd. Recent Development Table 78. Qilu Animal Health Products Co., Ltd. Company Information Table 79. Qilu Animal Health Products Co., Ltd. Business Overview Table 80. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 82. Qilu Animal Health Products Co., Ltd. Recent Development Table 83. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information Table 84. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview Table 85. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 87. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Development Table 88. Hebei New Century Pharmaceutical Co., Ltd. Company Information Table 89. Hebei New Century Pharmaceutical Co., Ltd. Business Overview Table 90. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 92. Hebei New Century Pharmaceutical Co., Ltd. Recent Development Table 93. Baimukang Animal Pharmaceutical Co., Ltd. Company Information Table 94. Baimukang Animal Pharmaceutical Co., Ltd. Business Overview Table 95. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio Table 97. Baimukang Animal Pharmaceutical Co., Ltd. Recent Development Table 98. Zoteis Company Information Table 99. Zoteis Business Overview Table 100. Zoteis Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Zoteis Flunixin Meglumine Injection Product Portfolio Table 102. Zoteis Recent Development Table 103. Virbac Animal Health India Private Limited Company Information Table 104. Virbac Animal Health India Private Limited Business Overview Table 105. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio Table 107. Virbac Animal Health India Private Limited Recent Development Table 108. Norbrook Company Information Table 109. Norbrook Business Overview Table 110. Norbrook Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Norbrook Flunixin Meglumine Injection Product Portfolio Table 112. Norbrook Recent Development Table 113. MSD Animal Health Company Information Table 114. MSD Animal Health Business Overview Table 115. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. MSD Animal Health Flunixin Meglumine Injection Product Portfolio Table 117. MSD Animal Health Recent Development Table 118. Merck Animal Health Company Information Table 119. Merck Animal Health Business Overview Table 120. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Merck Animal Health Flunixin Meglumine Injection Product Portfolio Table 122. Merck Animal Health Recent Development Table 123. Bengal Remedies Limited Company Information Table 124. Bengal Remedies Limited Business Overview Table 125. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio Table 127. Bengal Remedies Limited Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Flunixin Meglumine Injection Distributors List Table 131. Flunixin Meglumine Injection Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Flunixin Meglumine Injection Product Image Figure 2. Global Flunixin Meglumine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flunixin Meglumine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Flunixin Meglumine Injection Sales (2021-2032) & (K Doses) Figure 5. Global Flunixin Meglumine Injection Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Flunixin Meglumine Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10ml/Dose Image Figure 9. 20ml/ Dose Image Figure 10. Global Flunixin Meglumine Injection Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 11. Global Flunixin Meglumine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2032) Figure 13. Global Flunixin Meglumine Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 14. Global Flunixin Meglumine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2032) Figure 16. Animal muscle pain Image Figure 17. Animal febrile disease Image Figure 18. Others Image Figure 19. Global Flunixin Meglumine Injection Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 20. Global Flunixin Meglumine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2032) Figure 22. Global Flunixin Meglumine Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 23. Global Flunixin Meglumine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 26. North America Flunixin Meglumine Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 28. Canada Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Mexico Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Europe Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 31. Europe Flunixin Meglumine Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 33. France Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. U.K. Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. Italy Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Netherlands Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Asia Pacific Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 38. Asia Pacific Flunixin Meglumine Injection Sales Market Share by Country (2021-2032) Figure 39. China Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 40. Japan Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. South Korea Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. Southeast Asia Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. India Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. Australia Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. South America, Middle East and Africa Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 46. South America, Middle East and Africa Flunixin Meglumine Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 48. South Africa Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. Saudi Arabia Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Turkey Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. Argentina Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. UAE Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. Egypt Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Chile Flunixin Meglumine Injection Sales and Growth Rate (2021-2032) & (K Doses) Figure 55. Global Flunixin Meglumine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Flunixin Meglumine Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Flunixin Meglumine Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Flunixin Meglumine Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Flunixin Meglumine Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 10ml/Dose
  • 20ml/ Dose
Applications
  • Animal muscle pain
  • Animal febrile disease
  • Others
Companies covered
  • Wuhan Huisheng Biological Technology Co., Ltd.
  • Shandong Zhongmu Veterinary Medicine Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Qilu Animal Health Products Co., Ltd.
  • Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
  • Hebei New Century Pharmaceutical Co., Ltd.
  • Baimukang Animal Pharmaceutical Co., Ltd.
  • Zoteis
  • Virbac Animal Health India Private Limited
  • Norbrook
  • MSD Animal Health
  • Merck Animal Health
  • Bengal Remedies Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Flunixin Meglumine Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Flunixin Meglumine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Flunixin Meglumine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Flunixin Meglumine Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Flunixin Meglumine Injection Market Dynamics
  1. 2.1 Flunixin Meglumine Injection Industry Trends
  2. 2.2 Flunixin Meglumine Injection Industry Drivers
  3. 2.3 Flunixin Meglumine Injection Industry Opportunities and Challenges
  4. 2.4 Flunixin Meglumine Injection Industry Restraints
3 Flunixin Meglumine Injection Market by Manufacturers
  1. 3.1 Global Flunixin Meglumine Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Flunixin Meglumine Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Flunixin Meglumine Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Flunixin Meglumine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Flunixin Meglumine Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Flunixin Meglumine Injection Manufacturers, Product Type & Application
  7. 3.7 Global Flunixin Meglumine Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Flunixin Meglumine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Flunixin Meglumine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Flunixin Meglumine Injection Tier 1, Tier 2, and Tier 3
4 Flunixin Meglumine Injection Market by Type
  1. 4.1 Flunixin Meglumine Injection Type Introduction
  2. 4.1.1 10ml/Dose
  3. 4.1.2 20ml/ Dose
  4. 4.2 Global Flunixin Meglumine Injection Sales by Type
  5. 4.2.1 Global Flunixin Meglumine Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Flunixin Meglumine Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Flunixin Meglumine Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Flunixin Meglumine Injection Revenue by Type
  9. 4.3.1 Global Flunixin Meglumine Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Flunixin Meglumine Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Flunixin Meglumine Injection Revenue Market Share by Type (2021-2032)
5 Flunixin Meglumine Injection Market by Application
  1. 5.1 Flunixin Meglumine Injection Application Introduction
  2. 5.1.1 Animal muscle pain
  3. 5.1.2 Animal febrile disease
  4. 5.1.3 Others
  5. 5.2 Global Flunixin Meglumine Injection Sales by Application
  6. 5.2.1 Global Flunixin Meglumine Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flunixin Meglumine Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Flunixin Meglumine Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Flunixin Meglumine Injection Revenue by Application
  10. 5.3.1 Global Flunixin Meglumine Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Flunixin Meglumine Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Flunixin Meglumine Injection Revenue Market Share by Application (2021-2032)
6 Global Flunixin Meglumine Injection Sales by Region
  1. 6.1 Global Flunixin Meglumine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flunixin Meglumine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Flunixin Meglumine Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Flunixin Meglumine Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Flunixin Meglumine Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Flunixin Meglumine Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Flunixin Meglumine Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Flunixin Meglumine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Flunixin Meglumine Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Flunixin Meglumine Injection Revenue by Region
  1. 7.1 Global Flunixin Meglumine Injection Revenue by Region
  2. 7.1.1 Global Flunixin Meglumine Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Flunixin Meglumine Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Flunixin Meglumine Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Flunixin Meglumine Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Flunixin Meglumine Injection Revenue (2021-2032)
  8. 7.2.2 North America Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Flunixin Meglumine Injection Revenue (2021-2032)
  11. 7.3.2 Europe Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Flunixin Meglumine Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Flunixin Meglumine Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Flunixin Meglumine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Huisheng Biological Technology Co., Ltd.
  2. 8.1.1 Wuhan Huisheng Biological Technology Co., Ltd. Company Information
  3. 8.1.2 Wuhan Huisheng Biological Technology Co., Ltd. Business Overview
  4. 8.1.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  6. 8.1.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
  7. 8.2 Shandong Zhongmu Veterinary Medicine Co., Ltd.
  8. 8.2.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Company Information
  9. 8.2.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Business Overview
  10. 8.2.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  12. 8.2.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
  13. 8.3 Shandong Lukang Pharmaceutical Co., Ltd.
  14. 8.3.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  18. 8.3.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Qilu Animal Health Products Co., Ltd.
  20. 8.4.1 Qilu Animal Health Products Co., Ltd. Company Information
  21. 8.4.2 Qilu Animal Health Products Co., Ltd. Business Overview
  22. 8.4.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  24. 8.4.5 Qilu Animal Health Products Co., Ltd. Recent Developments
  25. 8.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
  26. 8.5.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  30. 8.5.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hebei New Century Pharmaceutical Co., Ltd.
  32. 8.6.1 Hebei New Century Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hebei New Century Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  36. 8.6.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Baimukang Animal Pharmaceutical Co., Ltd.
  38. 8.7.1 Baimukang Animal Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Baimukang Animal Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Portfolio
  42. 8.7.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Zoteis
  44. 8.8.1 Zoteis Company Information
  45. 8.8.2 Zoteis Business Overview
  46. 8.8.3 Zoteis Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zoteis Flunixin Meglumine Injection Product Portfolio
  48. 8.8.5 Zoteis Recent Developments
  49. 8.9 Virbac Animal Health India Private Limited
  50. 8.9.1 Virbac Animal Health India Private Limited Company Information
  51. 8.9.2 Virbac Animal Health India Private Limited Business Overview
  52. 8.9.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Portfolio
  54. 8.9.5 Virbac Animal Health India Private Limited Recent Developments
  55. 8.10 Norbrook
  56. 8.10.1 Norbrook Company Information
  57. 8.10.2 Norbrook Business Overview
  58. 8.10.3 Norbrook Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Norbrook Flunixin Meglumine Injection Product Portfolio
  60. 8.10.5 Norbrook Recent Developments
  61. 8.11 MSD Animal Health
  62. 8.11.1 MSD Animal Health Company Information
  63. 8.11.2 MSD Animal Health Business Overview
  64. 8.11.3 MSD Animal Health Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MSD Animal Health Flunixin Meglumine Injection Product Portfolio
  66. 8.11.5 MSD Animal Health Recent Developments
  67. 8.12 Merck Animal Health
  68. 8.12.1 Merck Animal Health Company Information
  69. 8.12.2 Merck Animal Health Business Overview
  70. 8.12.3 Merck Animal Health Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Animal Health Flunixin Meglumine Injection Product Portfolio
  72. 8.12.5 Merck Animal Health Recent Developments
  73. 8.13 Bengal Remedies Limited
  74. 8.13.1 Bengal Remedies Limited Company Information
  75. 8.13.2 Bengal Remedies Limited Business Overview
  76. 8.13.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Portfolio
  78. 8.13.5 Bengal Remedies Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flunixin Meglumine Injection Value Chain Analysis
  2. 9.1.1 Flunixin Meglumine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flunixin Meglumine Injection Production Mode & Process
  6. 9.2 Flunixin Meglumine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flunixin Meglumine Injection Distributors
  9. 9.2.3 Flunixin Meglumine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst